BMGL — Basel Medical Cashflow Statement
0.000.00%
- $28.05m
- $23.04m
- SG$10.05m
Annual cashflow statement for Basel Medical, fiscal year end - June 30th, SGD millions except per share, conversion factor applied.
2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Net Income/Starting Line | 2.39 | 2.13 | 2.4 |
| Depreciation | |||
| Non-Cash Items | 0.1 | 0.149 | 0.171 |
| Other Non-Cash Items | |||
| Changes in Working Capital | -0.27 | -0.238 | -0.595 |
| Change in Accounts Receivable | |||
| Change in Inventories | |||
| Change in Accounts Payable | |||
| Other Operating Cash Flow | |||
| Cash from Operating Activities | 2.79 | 2.6 | 2.51 |
| Capital Expenditures | -0.088 | -0.006 | -0.008 |
| Purchase of Fixed Assets | |||
| Cash from Investing Activities | -0.088 | -0.006 | -0.008 |
| Financing Cash Flow Items | -0.765 | -0.599 | 1.16 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | -12.9 | -2.94 | -1.77 |
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | -10.2 | -0.346 | 0.734 |